Clinical Trials in Cleveland

Showing 5761-5780 of 19,775 trials

MIP Versus PCNL for Kidney Stone Disease

NCT04767919

The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. The results of this study will help guide the decision making regarding these two procedures in the US population and provide further insight into the utility and safety of these procedures. A cost analysis will be performed, and it is hypothesized that the reusable components of the Storz MIP set will result in lower costs of the mini-PCNL procedure compared to standard PCNL.

Kidney Stone

University of California, San Diego75 participantsStarted Jan 2021

Phoenix, Arizona, United States • San Diego, California, United States • Cleveland, Ohio, United States +3 more locations

TERMINATEDPhase 2/346 miles

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

NCT04804033

The purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.

Migraine

Pfizer1,753 participantsStarted Mar 2021

Phoenix, Arizona, United States • Tucson, Arizona, United States • Canoga Park, California, United States +113 more locations

MIP Versus PCNL for Kidney Stone Disease

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Find Trials by Condition in Cleveland

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

PArtial REbreathing for Migraine With Aura 1

Kids FACE FEARS Comparative Effectiveness Research

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Oxytocin and Brain Responses in Maternal Addiction

Walking and mHealth to Increase Participation in Parkinson Disease

A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples